Cargando…
An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
The aim of this study was to measure the potential of production and the capacity used in the pharmaceutical industry. Capacity use is the actual production rate to the potential output, which reflects the gap between actual production and production capacity. Through econometric methods, translog c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843327/ https://www.ncbi.nlm.nih.gov/pubmed/29552074 |
_version_ | 1783305069940178944 |
---|---|
author | Annabi, Majid Kebriaeezadeh, Abbas Mohammadi, Timor Marashi Shoshtari, Seyed Nasrolah Abedin Dorkoosh, Farid Pourreza, Abolghasem Heydari, Hassan |
author_facet | Annabi, Majid Kebriaeezadeh, Abbas Mohammadi, Timor Marashi Shoshtari, Seyed Nasrolah Abedin Dorkoosh, Farid Pourreza, Abolghasem Heydari, Hassan |
author_sort | Annabi, Majid |
collection | PubMed |
description | The aim of this study was to measure the potential of production and the capacity used in the pharmaceutical industry. Capacity use is the actual production rate to the potential output, which reflects the gap between actual production and production capacity. Through econometric methods, translog cost function in the short run along with functions of share cost of production factors is estimated through seemingly unrelated repeated regression (SURE) as a multivariate regression analysis provided by zeller. During the study the capacity used is decreasing. The capacity used, which calculated by weighted average, also decreased and the amount during the study period is much less than the simple average of the industry. Average capacity utilization in the industry over five years of study is equal to 57% while the average capacity used calculated by the weighted of industry average is 37%. To enhance the economic potential requires a proper use of resources, creation of favorable economic structure and productivity of the industry. Due to the large amount of unused capacity in the pharmaceutical industry there is no need to invest anymore unless in new grounds and it is obvious that more investment will change using capacity. |
format | Online Article Text |
id | pubmed-5843327 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-58433272018-03-16 An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012 Annabi, Majid Kebriaeezadeh, Abbas Mohammadi, Timor Marashi Shoshtari, Seyed Nasrolah Abedin Dorkoosh, Farid Pourreza, Abolghasem Heydari, Hassan Iran J Pharm Res Original Article The aim of this study was to measure the potential of production and the capacity used in the pharmaceutical industry. Capacity use is the actual production rate to the potential output, which reflects the gap between actual production and production capacity. Through econometric methods, translog cost function in the short run along with functions of share cost of production factors is estimated through seemingly unrelated repeated regression (SURE) as a multivariate regression analysis provided by zeller. During the study the capacity used is decreasing. The capacity used, which calculated by weighted average, also decreased and the amount during the study period is much less than the simple average of the industry. Average capacity utilization in the industry over five years of study is equal to 57% while the average capacity used calculated by the weighted of industry average is 37%. To enhance the economic potential requires a proper use of resources, creation of favorable economic structure and productivity of the industry. Due to the large amount of unused capacity in the pharmaceutical industry there is no need to invest anymore unless in new grounds and it is obvious that more investment will change using capacity. Shaheed Beheshti University of Medical Sciences 2017 /pmc/articles/PMC5843327/ /pubmed/29552074 Text en © 2017 by School of Pharmacy,Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Annabi, Majid Kebriaeezadeh, Abbas Mohammadi, Timor Marashi Shoshtari, Seyed Nasrolah Abedin Dorkoosh, Farid Pourreza, Abolghasem Heydari, Hassan An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012 |
title | An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012 |
title_full | An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012 |
title_fullStr | An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012 |
title_full_unstemmed | An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012 |
title_short | An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012 |
title_sort | estimation of the potential utilization in iranian pharmaceutical industry involved in the stock exchange, 2008-2012 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843327/ https://www.ncbi.nlm.nih.gov/pubmed/29552074 |
work_keys_str_mv | AT annabimajid anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT kebriaeezadehabbas anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT mohammaditimor anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT marashishoshtariseyednasrolah anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT abedindorkooshfarid anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT pourrezaabolghasem anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT heydarihassan anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT annabimajid estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT kebriaeezadehabbas estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT mohammaditimor estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT marashishoshtariseyednasrolah estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT abedindorkooshfarid estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT pourrezaabolghasem estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 AT heydarihassan estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012 |